On the public citation graph

Synthesis, Biological Evaluation, and Molecular Modeling Studies of a Novel, Peripherally Selective Inhibitor of Catechol-O-methyltransferase

0 signed · 63 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/elps.1150181505openalex-snapshot
SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling
inferredcites →https://doi.org/10.1002/hlca.19890720511openalex-snapshot
Catechol‐O‐methyltransferase‐Inhibiting Pyrocatechol Derivatives: Synthesis and Structure‐Activity Studies
inferredcites →https://doi.org/10.1006/jmbi.1996.0897openalex-snapshot
Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen
inferredcites →https://doi.org/10.1007/978-1-4615-4141-7_7openalex-snapshot
Handling Information from 3D Grid Maps for QSAR Studies
inferredcites →https://doi.org/10.1007/bf00124324openalex-snapshot
A genetic algorithm for flexible molecular overlay and pharmacophore elucidation
inferredcites →https://doi.org/10.1016/0165-6147(89)90075-8openalex-snapshot
New selective COMT inhibitors: useful adjuncts for Parkinson's disease?
inferredcites →https://doi.org/10.1016/0165-6147(89)90076-xopenalex-snapshot
Drugs interacting with 5-HT systems show promise for treatment of eating disorders
inferredcites →https://doi.org/10.1016/0304-3940(91)90422-popenalex-snapshot
The significance of 3-O-methyldopa concentrations in the cerebrospinal fluid in the pathogenesis of wearing-off phenomenon in Parkinson's disease
inferredcites →https://doi.org/10.1016/s0140-6736(05)61511-5openalex-snapshot
Tolcapone and fulminant hepatitis
inferredcites →https://doi.org/10.1016/s0166-1280(99)00360-7openalex-snapshot
Molecular fields in quantitative structure–permeation relationships: the VolSurf approach
inferredcites →https://doi.org/10.1016/s0928-0987(00)00162-7openalex-snapshot
VolSurf: a new tool for the pharmacokinetic optimization of lead compounds
inferredcites →https://doi.org/10.1021/jm00124a017openalex-snapshot
Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors
inferredcites →https://doi.org/10.1021/jm0109964openalex-snapshot
Synthesis of 1-(3,4-Dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and Derivatives as Potent and Long-Acting Peripheral Inhibitors of Catechol-O-methyltransferase
inferredcites →https://doi.org/10.1021/jm0200299openalex-snapshot
Simple, Intuitive Calculations of Free Energy of Binding for Protein−Ligand Complexes. 1. Models without Explicit Constrained Water
inferredcites →https://doi.org/10.1021/jm990968+openalex-snapshot
Predicting Blood−Brain Barrier Permeation from Three-Dimensional Molecular Structure
inferredcites →https://doi.org/10.1038/368354a0openalex-snapshot
Crystal structure of catechol O-methyltransferase
inferredcites →https://doi.org/10.1038/368358a0openalex-snapshot
Erratum: Parasitism, mutation accumulation and the maintenance of sex
inferredcites →https://doi.org/10.1107/s0108768101004359openalex-snapshot
Experimental electron density of urea–phosphoric acid (1/1) at 100 K
inferredcites →https://doi.org/10.1124/mol.62.4.795openalex-snapshot
Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application
inferredcites →https://doi.org/10.1172/jci106831openalex-snapshot
Peripheral Aromatic L-Amino Acids Decarboxylase Inhibitor in Parkinsonism. I. EFFECT ON O-METHYLATED METABOLITES OF L-DOPA-2-14C
inferredcites →https://doi.org/10.1177/0091270003258666openalex-snapshot
Pharmacokinetic and Pharmacodynamic Profiles of BIA 3–202, a Novel Catechol‐O‐Methyltransferase (COMT) Inhibitor, during Multiple‐Dose Administration to Healthy Subjects
inferredcites →https://doi.org/10.1358/dof.1991.016.08.142757openalex-snapshot
Ro 40-7592
inferredcites →https://doi.org/10.2165/00126839-200304040-00001openalex-snapshot
Pharmacokinetics and Pharmacodynamics of BIA 3-202, a Novel COMT Inhibitor, during First Administration to Humans

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/jcc.22926openalex-snapshot
Computation of the binding affinities of catechol‐O‐methyltransferase inhibitors: Multisubstate relative free energy calculations
inferred← citeshttps://doi.org/10.1002/qsar.200730053openalex-snapshot
A 3‐D QSAR Study of Catechol‐O‐Methyltransferase Inhibitors Using CoMFA and CoMSIA
inferred← citeshttps://doi.org/10.1007/978-1-4020-9787-4_10openalex-snapshot
Addendum 2005–2008
inferred← citeshttps://doi.org/10.1007/978-1-4020-9787-4_22openalex-snapshot
Addendum 2005–2008
inferred← citeshttps://doi.org/10.1007/978-1-4020-9787-4_8openalex-snapshot
Addendum 2000–2008
inferred← citeshttps://doi.org/10.1007/s11030-015-9598-yopenalex-snapshot
Non-dopamine receptor ligands for the treatment of Parkinson’s disease. Insight into the related chemical/property space
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00005-3openalex-snapshot
Biochemistry and Pharmacology of Catechol-O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-381326-8.00006-5openalex-snapshot
The Chemistry of Catechol-O-Methyltransferase Inhibitors
inferred← citeshttps://doi.org/10.1016/b978-0-12-823974-2.00029-2openalex-snapshot
Catechol-O-methyltransferase (COMT)
inferred← citeshttps://doi.org/10.1016/b978-0-443-18611-0.00018-8openalex-snapshot
Applications of piperazine scaffold in drug design
inferred← citeshttps://doi.org/10.1016/j.bbrc.2008.11.085openalex-snapshot
Crystal structures of rat catechol-O-methyltransferase complexed with coumarine-based inhibitor
inferred← citeshttps://doi.org/10.1016/j.bioorg.2019.103418openalex-snapshot
Neurological and psychiatric management using COMT inhibitors: A review
inferred← citeshttps://doi.org/10.1016/j.bioorg.2021.105130openalex-snapshot
The inhibition of catechol O-methyltransferase and monoamine oxidase by tetralone and indanone derivatives substituted with the nitrocatechol moiety
inferred← citeshttps://doi.org/10.1016/j.bmcl.2020.127188openalex-snapshot
Evaluation of nitrocatechol chalcone and pyrazoline derivatives as inhibitors of catechol-O-methyltransferase and monoamine oxidase
inferred← citeshttps://doi.org/10.1016/j.ejmech.2008.06.017openalex-snapshot
Diazinium salts with dihydroxyacetophenone skeleton: Syntheses and antimicrobial activity
inferred← citeshttps://doi.org/10.1016/j.ejmech.2022.114378openalex-snapshot
Discovery of small-molecule compounds and natural products against Parkinson's disease: Pathological mechanism and structural modification
inferred← citeshttps://doi.org/10.1016/j.jep.2009.10.030openalex-snapshot
Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease
inferred← citeshttps://doi.org/10.1016/j.jmb.2008.04.040openalex-snapshot
Crystal Structures of Human 108V and 108M Catechol O-Methyltransferase
inferred← citeshttps://doi.org/10.1016/j.jsb.2008.11.012openalex-snapshot
Crystal structures of the Apo and Holo form of rat catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1016/j.lfs.2015.04.026openalex-snapshot
Effect of intracerebral hydroxytyrosol and its nitroderivatives on striatal dopamine metabolism: A study by in vivo microdialysis
inferred← citeshttps://doi.org/10.1021/acs.jafc.6b00401openalex-snapshot
Evaluation of the Bioavailability and Metabolism of Nitroderivatives of Hydroxytyrosol Using Caco-2 and HepG2 Human Cell Models
inferred← citeshttps://doi.org/10.1021/jm0580454openalex-snapshot
Synthesis and Biological Evaluation of a Novel Series of “Ortho-Nitrated” Inhibitors of Catechol- O -methyltransferase
inferred← citeshttps://doi.org/10.1021/jm1001524openalex-snapshot
Discovery of a Long-Acting, Peripherally Selective Inhibitor of Catechol-O-methyltransferase
inferred← citeshttps://doi.org/10.1021/jm500572bopenalex-snapshot
Medicinal Chemistry of CatecholO-Methyltransferase (COMT) Inhibitors and Their Therapeutic Utility
inferred← citeshttps://doi.org/10.1039/9781849737357-00083openalex-snapshot
Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones
inferred← citeshttps://doi.org/10.1039/c4ra09872bopenalex-snapshot
The effect of hydroxytyrosol and its nitroderivatives on catechol-O-methyl transferase activity in rat striatal tissue
inferred← citeshttps://doi.org/10.1074/jbc.m109.080390openalex-snapshot
Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
inferred← citeshttps://doi.org/10.1080/00397910701821077openalex-snapshot
Convenient Synthesis of Tolcapone, a Selective Catechol‐O‐methyltransferase Inhibitor
inferred← citeshttps://doi.org/10.1080/17460441.2020.1691165openalex-snapshot
Cheminformatics and virtual screening studies of COMT inhibitors as potential Parkinson’s disease therapeutics
inferred← citeshttps://doi.org/10.1093/toxsci/kfp236openalex-snapshot
Capture Compound Mass Spectrometry Sheds Light on the Molecular Mechanisms of Liver Toxicity of Two Parkinson Drugs
inferred← citeshttps://doi.org/10.1111/bcp.12169openalex-snapshot
Structure-based drug design of catechol-O-methyltransferase inhibitors for CNS disorders
inferred← citeshttps://doi.org/10.1111/j.1527-3458.2007.00020.xopenalex-snapshot
Catechol‐ O ‐methyltransferase and Its Inhibitors in Parkinson's Disease
inferred← citeshttps://doi.org/10.1124/mol.106.023119openalex-snapshot
Comparative Study of ortho- and meta-Nitrated Inhibitors of Catechol-O-methyltransferase: Interactions with the Active Site and Regioselectivity of O-Methylation
inferred← citeshttps://doi.org/10.14295/bjs.v3i10.634openalex-snapshot
Interaction of dihydrofuran-2-one and its derivatives with either MAO-B or COMT enzymes using a theoretical model
inferred← citeshttps://doi.org/10.2174/1871524919666190619090852openalex-snapshot
Evaluation of Selected Natural Compounds as Dual Inhibitors of Catechol-O-Methyltransferase and Monoamine Oxidase
inferred← citeshttps://doi.org/10.2174/187152712800672436openalex-snapshot
Role of Catechol-O-Methyltransferase (COMT)-Dependent Processes in Parkinson’s Disease and L-DOPA Treatment
inferred← citeshttps://doi.org/10.3390/molecules22122076openalex-snapshot
The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease
inferred← citeshttps://doi.org/10.3390/pharmaceutics16060708openalex-snapshot
Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?
inferred← citeshttps://doi.org/10.3390/pr7120940openalex-snapshot
Theoretical and Experimental Approaches Aimed at Drug Design Targeting Neurodegenerative Diseases
inferred← citeshttps://doi.org/10.34626/wryn-4b60openalex-snapshot
Opicapone Sulfation: Sulfotransferase Isoforms Characterization
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.